Smart inhalers track Kids' asthma attacks to build better action plans

NCT ID NCT04810169

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study observed 120 children with asthma, aged 3 to 11, using smart inhalers to track how and when they used emergency medication at home. Parents also answered questions via a mobile app about symptoms and treatment effectiveness. The goal was to gather real-world data to create more practical asthma action plans for families.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
smart inhaler
What this could lead to
If successful, this could lead to better, data-driven asthma action plans for children, helping families manage attacks more effectively.
What could go wrong
This is an observational study, not a treatment trial. It may not directly change outcomes, and results may not apply to all children with asthma.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Necker-Enfants malades

    Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.